Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Voyager Therapeutics (United States)
company in Cambridge, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireVoyager Reports Second Quarter 2025 Financial and Operating Results - Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to pipeline